Advanced search
Publication Cover
OncoImmunology Volume 6, 2017 - Issue 7
Submit an article Journal homepage
1,429
Views
18
CrossRef citations to date
0
Altmetric
Original Research

Mapping the human T cell repertoire to recurrent driver mutations in MYD88 and EZH2 in lymphoma

Julie S. NielsenTrev and Joyce Deeley Research Centre, British Columbia Cancer Agency, Victoria, British Columbia, CanadaCorrespondence[email protected]
,
Andrew R. ChangTrev and Joyce Deeley Research Centre, British Columbia Cancer Agency, Victoria, British Columbia, Canada
,
Darin A. WickTrev and Joyce Deeley Research Centre, British Columbia Cancer Agency, Victoria, British Columbia, Canada
,
Colin G. SedgwickTrev and Joyce Deeley Research Centre, British Columbia Cancer Agency, Victoria, British Columbia, Canada
,
Zusheng ZongDepartment of Molecular Biology and Biochemistry, Simon Fraser University, Burnaby, British Columbia, Canada
,
Andrew J. MungallCanada's Michael Smith Genome Sciences Centre, British Columbia Cancer Agency, Vancouver, British Columbia, CanadaORCID Iconhttp://orcid.org/0000-0002-0905-2742
ORCID Icon,
Spencer D. MartinTrev and Joyce Deeley Research Centre, British Columbia Cancer Agency, Victoria, British Columbia, Canada;Canada's Michael Smith Genome Sciences Centre, British Columbia Cancer Agency, Vancouver, British Columbia, Canada
,
Natalie N. KinlochFaculty of Health Sciences, Simon Fraser University, Burnaby, British Columbia, Canada
,
Susann Ott-LangerTrev and Joyce Deeley Research Centre, British Columbia Cancer Agency, Victoria, British Columbia, Canada
,
Zabrina L. BrummeFaculty of Health Sciences, Simon Fraser University, Burnaby, British Columbia, Canada
,
Steven P. TreonBing Center for Waldenstrom's Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA, USA;Department of Medicine, Harvard Medical School, Boston, MA, USA
,
Joseph M. ConnorsCentre for Lymphoid Cancer, British Columbia Cancer Agency, Vancouver, British Columbia, Canada;The University of British Columbia, Vancouver, British Columbia, Canada
,
Randy D. GascoyneCentre for Lymphoid Cancer, British Columbia Cancer Agency, Vancouver, British Columbia, Canada;The University of British Columbia, Vancouver, British Columbia, Canada
,
John R. WebbTrev and Joyce Deeley Research Centre, British Columbia Cancer Agency, Victoria, British Columbia, Canada;Department of Biochemistry and Microbiology, University of Victoria, Victoria, British Columbia, Canada
,
Brian R. BerryDepartment of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada
,
Ryan D. MorinDepartment of Molecular Biology and Biochemistry, Simon Fraser University, Burnaby, British Columbia, Canada;Canada's Michael Smith Genome Sciences Centre, British Columbia Cancer Agency, Vancouver, British Columbia, Canada;Faculty of Health Sciences, Simon Fraser University, Burnaby, British Columbia, Canada
,
Nicol MacphersonDepartment of Medical Oncology, British Columbia Cancer Agency, Victoria, British Columbia, Canada
&
Brad H. NelsonTrev and Joyce Deeley Research Centre, British Columbia Cancer Agency, Victoria, British Columbia, Canada;Department of Biochemistry and Microbiology, University of Victoria, Victoria, British Columbia, Canada;Department of Medical Genetics, University of British Columbia, Vancouver, British Columbia, Canada
 show all
Article: e1321184 | Received 11 Jan 2017, Accepted 15 Apr 2017, Published online: 28 Jun 2017

Citations (18)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Karima Amaador, Anne Martens, Renate de Boer, Joanne Rietveld, Mirjam Heemskerk, Caroline E. Rutten, Eric Eldering, Marie-José Kersten, Arnon P. Kater, Josephine Vos & Sanne Tonino. (2022) T-cell subset composition and functionality in patients with Waldenström’s macroglobulinemia. Leukemia & Lymphoma 63:6, pages 1469-1473.
Read now
Wenyujing Zhou & Weihong Chen. (2021) Development of molecular intervention strategies for B-cell lymphoma. Expert Review of Hematology 14:2, pages 241-252.
Read now
Zijun Y. Xu-Monette & Ken H. Young. (2020) Therapeutic vaccines for aggressive B-cell lymphoma. Leukemia & Lymphoma 61:13, pages 3038-3051.
Read now
Spencer D. Martin, Darin A. Wick, Julie S. Nielsen, Nicole Little, Robert A. Holt & Brad H. Nelson. (2018) A library-based screening method identifies neoantigen-reactive T cells in peripheral blood prior to relapse of ovarian cancer. OncoImmunology 7:1.
Read now

Articles from other publishers (14)

Miguel Alcoceba, María García-Álvarez, Alejandro Medina, Rebeca Maldonado, Verónica González-Calle, María Carmen Chillón, María Eugenia Sarasquete, Marcos González, Ramón García-Sanz & Cristina Jiménez. (2022) MYD88 Mutations: Transforming the Landscape of IgM Monoclonal Gammopathies. International Journal of Molecular Sciences 23:10, pages 5570.
Crossref
Andrea CastroMaurizio Zanetti & Hannah Carter. (2021) Neoantigen Controversies. Annual Review of Biomedical Data Science 4:1, pages 227-253.
Crossref
Özcan Çınar, Bernadette Brzezicha, Corinna Grunert, Peter Michael Kloetzel, Christin Beier, Caroline Anna Peuker, Ulrich Keller, Antonio Pezzutto & Antonia Busse. (2021) High-affinity T-cell receptor specific for MyD88 L265P mutation for adoptive T-cell therapy of B-cell malignancies. Journal for ImmunoTherapy of Cancer 9:7, pages e002410.
Crossref
Alessandra Trojani, Barbara Di Camillo, Luca Emanuele Bossi, Livia Leuzzi, Antonino Greco, Alessandra Tedeschi, Anna Maria Frustaci, Marina Deodato, Giulia Zamprogna, Alessandro Beghini & Roberto Cairoli. (2021) Identification of a Candidate Gene Set Signature for the Risk of Progression in IgM MGUS to Smoldering/Symptomatic Waldenström Macroglobulinemia (WM) by a Comparative Transcriptome Analysis of B Cells and Plasma Cells. Cancers 13:8, pages 1837.
Crossref
Yue Zhao, Alexey V. Baldin, Orkhan Isayev, Jens Werner, Andrey A. ZamyatninJr.Jr. & Alexandr V. Bazhin. (2021) Cancer Vaccines: Antigen Selection Strategy. Vaccines 9:2, pages 85.
Crossref
Qing Li & Zhen-Yu Ding. (2020) The Ways of Isolating Neoantigen-Specific T Cells. Frontiers in Oncology 10.
Crossref
Morten Orebo Holmström, Sabrina Cordua, Vibe Skov, Lasse Kjær, Niels Pallisgaard, Christina Ellervik, Hans Carl Hasselbalch & Mads Hald Andersen. (2020) Evidence of immune elimination, immuno-editing and immune escape in patients with hematological cancer. Cancer Immunology, Immunotherapy 69:2, pages 315-324.
Crossref
Qinan Yin, Jiaxing Tang & Xuekai Zhu. (2019) Next-generation sequencing technologies accelerate advances in T-cell therapy for cancer. Briefings in Functional Genomics 18:2, pages 119-128.
Crossref
Susumu Iiizumi, Junya Ohtake, Naoko Murakami, Taku Kouro, Mamoru Kawahara, Fumiko Isoda, Hiroshi Hamana, Hiroyuki Kishi, Norihiro Nakamura & Tetsuro Sasada. (2019) Identification of Novel HLA Class II-Restricted Neoantigens Derived from Driver Mutations. Cancers 11:2, pages 266.
Crossref
Morten O. Holmström, Shamaila M. Ahmad, Uffe Klausen, Simone K. Bendtsen, Evelina Martinenaite, Caroline H. Riley, Inge M. Svane, Lasse Kjær, Vibe Skov, Christina Ellervik, Niels Pallisgaard, Hans C. Hasselbalch & Mads H. Andersen. (2019) High frequencies of circulating memory T cells specific for calreticulin exon 9 mutations in healthy individuals. Blood Cancer Journal 9:2.
Crossref
Weijing Cai, Dapeng Zhou, Weibo Wu, Wen Ling Tan, Jiaqian Wang, Caicun Zhou & Yanyan Lou. (2018) MHC class II restricted neoantigen peptides predicted by clonal mutation analysis in lung adenocarcinoma patients: implications on prognostic immunological biomarker and vaccine design. BMC Genomics 19:1.
Crossref
Alexander N. R. Weber, Yamel Cardona Gloria, Özcan Çınar, H. Christian Reinhardt, Antonio Pezzutto & Olaf-Oliver Wolz. (2018) Oncogenic MYD88 mutations in lymphoma: novel insights and therapeutic possibilities. Cancer Immunology, Immunotherapy 67:11, pages 1797-1807.
Crossref
Xinfang Yu, Wei Li, Qipan Deng, Ling Li, Eric D. Hsi, Ken H. Young, Mingzhi Zhang & Yong Li. (2018) MYD88 L265P Mutation in Lymphoid Malignancies . Cancer Research 78:10, pages 2457-2462.
Crossref
J. H. van Krieken. (2017) New developments in the pathology of malignant lymphoma. A review of the literature published from September–August 2017. Journal of Hematopathology 10:3-4, pages 117-127.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.